CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
CPXX was delisted on the 11th of July, 2016.
20 hedge funds and large institutions have $5.23M invested in CELATOR PHARMACEUTICALS INC. COMMON STOCK in 2015 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 5 closing their positions.
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
25% more funds holding
Funds holding: 16 → 20 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
20% less capital invested
Capital invested by funds: $6.52M → $5.23M (-$1.29M)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$337K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$149K |
| 3 |
Goldman Sachs
New York
|
+$77.2K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$68K |
| 5 |
Bank of New York Mellon
New York
|
+$48.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCCM
Nine Chapters Capital Management
Short Hills,
New Jersey
|
-$106K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$48.3K |
| 3 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
-$31K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$30.9K |
| 5 |
Walleye Trading
New York
|
-$6K |
CPXX Hedge Fund Activity: Q3 2015 in Review
20 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) for Q3 2015, worth a combined $5.23M — down 20% from $6.52M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new CPXX positions and 5 closed out — a net gain of 4 holders — while 3 added to existing stakes and 5 trimmed.
The largest buyer was Vanguard Group, adding an estimated $337K. The largest seller was Nine Chapters Capital Management, exiting entirely with an estimated $106K sold.
- 20 institutional investors held CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) as of Q3 2015, up from 16 in Q2 2015.
- Funds reported $5.23M of CELATOR PHARMACEUTICALS INC. COMMON STOCK stock for Q3 2015, down 20% quarter-over-quarter.
- 9 funds opened new CELATOR PHARMACEUTICALS INC. COMMON STOCK positions in Q3 2015 and 5 closed out, a net change of +4 holders.
- The largest CELATOR PHARMACEUTICALS INC. COMMON STOCK buyer in Q3 2015 was Vanguard Group, an estimated $337K added.
- The largest CELATOR PHARMACEUTICALS INC. COMMON STOCK seller in Q3 2015 was Nine Chapters Capital Management, an estimated $106K sold.
Based on aggregated 13F filings for Q3 2015.